Australia markets open in 1 hour

Axsome Therapeutics, Inc. (AXSM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
65.72-3.99 (-5.72%)
At close: 04:00PM EDT
66.10 +0.38 (+0.58%)
After hours: 05:58PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
270,600
270,600
50,037
0
0
Cost of revenue
26,065
26,065
5,198
0
0
Gross profit
244,535
244,535
44,839
0
0
Operating expenses
Research development
97,944
97,944
57,947
58,061
70,245
Selling general and administrative
323,123
323,123
159,254
66,646
28,897
Total operating expenses
427,442
427,442
221,340
124,707
99,088
Operating income or loss
-182,907
-182,907
-176,501
-124,707
-99,088
Interest expense
6,453
6,453
7,335
5,696
2,566
Total other income/expenses net
-48,918
-48,918
-3,298
-
-1,247
Income before tax
-238,278
-238,278
-187,134
-130,403
-102,901
Income tax expense
960
960
0
0
-
Income from continuing operations
-239,238
-239,238
-187,134
-130,403
-102,901
Net income
-239,238
-239,238
-187,134
-130,403
-102,901
Net income available to common shareholders
-239,238
-239,238
-187,134
-130,403
-102,901
Basic EPS
-4.57
-5.27
-4.60
-3.47
-2.77
Diluted EPS
-4.57
-5.27
-4.60
-3.47
-2.77
Basic average shares
44,457
45,425
40,656
37,619
37,207
Diluted average shares
44,457
45,425
40,656
37,619
37,207